Category: ECP

CSE ECP ENT Fashion

Innokin Technology Is Extremely Proud to Announce the Immediate Launch the iTaste MVP3.0 Advanced Personal Vaporizer

admin

SHENZHEN, China, January 26, 2015 /PRNewswire/ — The iTaste MVP3.0 is the newest in the line of internationally bestselling iTaste MVP vaporizers and sets the standard for top quality, high capacity, powerful and smart advanced personal vaporizers and E Cigarette.

Designed and upgraded based on feedback from vapers, top reviewers and friends from all over the world, The iTaste MVP3.0 is more powerful with a maximum output of 30 Watts and can fire a wide range of coil resistances from .4 to 2.5 ohms.

Made with the highest quality materials, the iTaste MVP3.0 is designed to be your powerful and reliable every day vape. Initially available in four sleek designs the iTaste MVP3.0 has a flush 510 thread connection with a gold plated spring loaded positive pin, durable stainless steel threading and an included ego threading adaptor for maximum compatibility.

The large OLED screen clearly displays all important information including tank-coil resistance (ohm), wattage & voltage and remaining battery power. The intelligent two button interface makes it easy to quickly find and set a precise power output to give you a perfect vape of flavor and clouds. Pushing the two buttons together displays the secondary screen with an ohms meter, battery level indicator and puff counter.

You should never have to wait to vape and the iTaste MVP3.0 is charged via a side micro-USB port and features Innokin’s “Vape while charging” technology so you can always be vaping.

Advanced safety features including 15 second firing cutoff, low voltage warning, atomizer short circuit protection and over discharge protection means you can vape with confidence.

You can use the MVP3.0’s high capacity internal battery to charge your electronic devices via the replaceable integrated micro-USB charging cable or USB port

The iTaste MVP3.0 has a variable voltage range of 3.0 – 9.0 Volts, adjustable in 0.1 volt increments, and a variable wattage range of 6.0 – 30.0 Watts, adjustable in 0.5 watts increments. The iTaste MVP3.0 uses vRMS DC current and is very accurate with a power deviation of 0.1 Watt. The full 30 Watt output is precisely maintained between resistances of 0.4 to 2.5 ohms. There is no wasted power and exact accuracy means you are always vaping the power level that you choose. vRMS provides superior precision in delivering the exact wattage Ohm’s Law requires and stable power means better vapor.

The iTaste MVP3.0 will be available at Authorized Innokin Vendors in early February 2015.

For more information including pricing and Authorized Vendor Locations please visit: http://innokin.com/index.php/en/product-listings-en/itaste-en/itaste-mvp-3-0.

You can be confident when buying an iTaste MVP3.0 because every Innokin iTaste product has a Unique Authentication Code which can be verified at http://www.innokin.com and the the iTaste MVP3.0 is also covered by Innokin’s 90 Day Limited Warranty program.

For more information, giveaways, and a great community visit Facebook page @Innokin.Technology and the Innokin subreddit (http://www.reddit.com/r/innokin ).

To become an Innokin Vendor please contact: Vendor@innokin.com

Photo – http://photos.prnewswire.com/prnh/20150126/171217
Photo – http://photos.prnewswire.com/prnh/20150126/171186

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/innokin-technology-is-extremely-proud-to-announce-the-immediate-launch-the-itaste-mvp30-advanced-personal-vaporizer-300025356.html

ECP ENT Fashion MEN SPT

Video Transcoders: A Business-critical Technology in Global Media and Entertainment

admin

– Speed, quality, cost, and flexibility will be critical as focus shifts from delivery to monetization, finds Frost & Sullivan

MOUNTAIN VIEW, Calif., Jan. 8, 2015 /PRNewswire/ — Fierce competition and consumer pressure is giving a boost to over-the-top (OTT) content volumes, intensifying the demand for video transcoders globally. With media and entertainment companies looking to deliver OTT multiscreen offerings at par with traditional primary screen content, both in terms of volume and quality of experience, they are investing significantly in digital content workflows and multi-screen transcoders. As industry focus shifts from delivery to monetization, product differentiation will hinge on speed, quality, density, operating cost, flexibility and future-proof architectures.

New analysis from Frost & Sullivan, Global Media and Entertainment Video Transcoder Market, finds that the market earned revenues of $270.0 million in 2013 and estimates this to reach $959.8 million by 2020. While adoption of on-premise products and solutions will continue, software- and platform-as-a-service for multi-screen workflows will gain faster traction due to their agility, scalability and convenience.

For complimentary access to more information on this research, please visit: http://bit.ly/1ApdXbu

“Ensuring high-quality, glitch-free transcoding across multiple generations of encodes and transcodes remains a crucial problem to solve, making this a technologically-intensive market,” said Frost & Sullivan Digital Media Principal Analyst Avni Rambhia. “Managing scale and agility requirements in a cost-efficient manner is an added dimension of complexity that is driving upgrades and investments in the global media and entertainment video transcoder market.”

While uptake continues to increase, prices are decreasing due to commoditized silicon and, ironically, the rise in cloud-based models is limiting market growth. The inability to fully monetize online video content also affects profits, although niches such as live sports and catch-up TV are beginning to yield dividends in the form of subscription revenues and sold-out advertisement inventories. Over time, advances in high-definition, 4K, high efficiency video coding (HEVC), and the emergence of commercial solutions over home-grown systems will counteract these restraints.

The advancement of online video platforms and video origin servers in the traditional video transcoders market is another challenge. Companies are responding either through portfolio expansion or establishing strategic partnerships. Strong brands with massive distribution channels, but dated internal technology, are acquiring smaller companies with cutting edge technology and limited go-to-market resources.

“Operators are looking for video to become an ‘it just works’ solution as opposed to a technologically-intricate deployment requiring continuous oversight and enhancement,” concluded Rambhia. “Accordingly, video transcoder vendors need to position themselves as long-term outsourcing partners for operators, as opposed to the traditional strategy of differentiating purely on format support and compression efficiency.”

Global Media and Entertainment Video Transcoder Market is part of the Digital Media (http://www.digitalmedia.frost.com) Growth Partnership Service program. Frost & Sullivan’s related studies include: Global Pay TV Video Encoders Market, Global Pay TV Middleware Market, Global Web and Mobile Analytics Market, and Global Big Data Analytics Market. All studies included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants.

Our “Growth Partnership” supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on “the next big thing”

Register:         Gain access to visionary innovation

Global Media and Entertainment Video Transcoder Market
NDBF-70

Contact:
Clarissa Castaneda
Corporate Communications – North America
P: +1-210-477-8481
F: +1-210-348-1003
E: clarissa.castaneda@frost.com

http://www.frost.com

ECP ENT Fashion

Shenzhen-based Mobile Equipment Maker FortuneShip Announces Worldwide Release of Microcinema Film Change

admin

SHENZHEN, China, December 19, 2014 /PRNewswire/ — We mostly lead uneventful lives akin to a person living in a box. A person, though, needs change and the opportunity to face challenges. What’s your life like? Change, a microcinema film released recently online by Shenzhen-based FortuneShip, has already received a great number of views and shares, becoming one of the hottest topics among mobile users and the recipient of much acclaim from the community.

“Never change” or “change?” Everyone is looking for the answer within. Do you really have the courage to “change?” The microcinema film Change provides viewers with an unusual answer.

Serving also as FortuneShip’s corporate video, the film tells a story about the results of endeavor, courage and what it means to have and act on a dream while revealing the changes in fate as a result of the power of individuals and of companies. In addition, the film demonstrates the innovation that went into the production of the video by incorporating FortuneShip’s development, innovation and production capabilities into the film’s content.

FortuneShip, a specialized OEM/ODM manufacturer of mobile terminal equipment, is committed to building a healthy mobile terminal ecosystem based on the philosophy of “innovation, pioneering, excellence and sharing.” The firm provides mobile terminal equipment including mobile phones, tablet PCs and data cards. Since inception in 2010, the company has maintained strong growth. FortuneShip has four manufacturing facilities, with monthly production capacity of 5 million units and has become a global OEM/ODM leader in mobile terminal equipment with a presence in more than 50 countries and regions across Europe, the Americas, Asia, the Middle East and Africa.

The film is available at https://www.youtube.com/watch?v=x5RLfTZoZ3M&list=UUBh68fzgGxcazvxSsiImh2A. For more information, follow FortuneShip on Twitter and Facebook.

For more information, please contact:

Cattie Zhang
Email: zhangchunmei@fortuneship.com
Telephone: 0086-755-26397209
Fax: 0086-755-21608700

To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/shenzhen-based-mobile-equipment-maker-fortuneship-announces-worldwide-release-of-microcinema-film-change-300012374.html

ECP Health Care NET WRK

Emerging Technologies Enable Smarter Monitoring of Assets, Push Industrial Testing, Inspection and Monitoring Market

admin

– Mechanical testing driven by supporting Mega Trends in consumer electronics, big data and beyond-BRIC markets, finds Frost & Sullivan

MOUNTAIN VIEW, Calif., Dec. 4, 2014 /PRNewswire/ — Increased emphasis on product quality, reliability and safety has boosted investments in new testing and inspection technologies. The convergence of industries and products has also given rise to a range of innovative test solutions. This trend is further driven by the requirements of Generation Y, which is generally more inclined towards communication, media and digital technologies. As a result, product development strategies of test equipment vendors will cater to their needs, aiming incorporate emerging technologies like touch-screens, intuitive software, and even interactive voice response.

As a result, product development strategies of test equipment vendors will incorporate emerging technologies like touch-screens, intuitive software, and even interactive voice response.

As a result, product development strategies of test equipment vendors will incorporate emerging technologies like touch-screens, intuitive software, and even interactive voice response.

Photo – http://photos.prnewswire.com/prnh/20141204/162397

New analysis from Frost & Sullivan, Impact of Mega Trends on the Mechanical Test Market, identifies and understands how key Mega Trends such as big data, emerging economies beyond BRIC (Brazil, Russia, India and China), and the rise of Gen Y will influence the mechanical test market in the years to come. The study covers nondestructive testing (NDT), condition monitoring, dimensional metrology and material testing.

For complimentary access to more information on this research, please visit: http://bit.ly/1w3EFse.

New infrastructure projects in markets beyond BRIC will be the biggest driver for capital expenditure-based industrial inspection and monitoring solutions. Potential game-changing countries include Indonesia, Turkey, the Middle East, and Africa. Markets will also see wide-scale adoption of big data platforms that enable continuous monitoring of critical and non-critical assets to maximize productivity and prevent costly shutdowns.

“Productivity trends in the consumer electronics industry, such as enhanced processing power, expanded memory, display technologies, lithium-ion batteries, and a shift toward touch-based devices, will directly impact tomorrow’s mechanical test equipment,” said Frost & Sullivan Measurement and Instrumentation Program Manager Vijay Mathew. “Equipment vendors are increasingly integrating these features into their devices as technologies continue to converge and solutions become more interactive, portable, connected and easy to navigate.”

Lack of skilled technicians and an aging workforce is a key challenge in the mechanical test industry. Though well-publicized infrastructure failures, aging infrastructures and growing investments in new infrastructure projects have incrementally increased demand for new technicians, the supply shortage continues. Coupled with shrinking budgets, end-user industries are compelled to outsource maintenance and inspection services.

“With buzzwords such as Industry 4.0, smart factories and smart manufacturing gaining interest, end users look to move away from traditional testing and inspection technologies and opt for automated solutions that can be integrated with modern production lines,” observed Mathew. “Inclusion of cloud-based software and networked systems and interfaces will also be crucial to meet the requirements of Industry 4.0.”

Impact of Mega Trends on the Mechanical Test Market is part of the Test & Measurement Growth Partnership Service program. Frost & Sullivan’s related studies include: Alternative Energy and NDT: Impact of Shale Gas and Oil Sands on the NDT Inspection Services Market, Beyond BRIC Opportunities for NDT Inspection Services Market: Middle East and North Africa, Current and New Opportunities for Metrology in the Automotive Industry, Analysis of the Emerging and Nontraditional Nondestructive Testing Equipment Market and World Material Testing Equipment Market. All studies included in subscriptions provide detailed market opportunities and industry trends evaluated following extensive interviews with market participants.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants.

Our “Growth Partnership” supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion

Join Us:           Join our community

Subscribe:       Newsletter on “the next big thing”

Register:         Gain access to visionary innovation

Impact of Mega Trends on the Mechanical Test Market
NDF1-30

Contact:
Ariel Brown
Corporate Communications – North America
P: (210) 247.2481
F: (210) 348.1003
E: ariel.brown@frost.com

Photo – http://photos.prnasia.com/prnh/20141204/8521407313

ECP Health Care

OCSiAl Group Receives Frost & Sullivan Technology Innovation Award for Its Game-Changing Carbon Nanotube Production Process

admin

— The patent-protected process allows commercialization of single-walled nanotubes that can revolutionize material science

MOUNTAIN VIEW, Calif., Dec. 2, 2014 /PRNewswire/ — Based on its recent analysis of the carbon nanotubes market, Frost & Sullivan recognizes OCSiAl Group with the 2014 North American Award for Technology Innovation for its OCSiAl TUBALL™ products. The high purity and large-scale production of the OCSiAl TUBALL™ products are potential game changers as commercialization of single-walled carbon nanotubes (SWNTs) has been a challenge.

OCSiAl receives 2014 North American Carbon Nanotubes Technology Innovation Award

OCSiAl receives 2014 North American Carbon Nanotubes Technology Innovation Award

Carbon nanotubes have the ability to change the characteristics of known materials — their structural strength, permeability, electrical conductivity, and thermal transport —  and even allow the creation of totally new products. SWNTs, in particular, have strong potential in advanced technologies, including high-performance composites, molecular electronics, and ultra-sensitive sensor devices. However, until now the uptake of SWNTs was slow due to high costs and greater processing difficulty when compared with multi-walled carbon nanotube production.

“OCSiAl has developed an industrial process to synthesize SWNTs that can be scaled up to eventually produce hundreds of thousands of tons of these nanoparticles, thereby potentially reducing production costs up to 100 times,” said Frost & Sullivan Senior Consultant Mike Valenti. “This ability to produce SWNTs in commercial scale quantities will initially drive the use of these nanoparticles in research, and then in high-end industrial and consumer applications.”

OCSiAl has designed its TUBALL™ product to contain a minimum of 75 percent SWNTs and less than 15 percent of non-carbon impurities, with the predominant non-carbon element being iron. Virtually all non-carbon species are encapsulated, providing highly crystalline nanotubes at a price close to one-fiftieth of that of comparable materials. These characteristics enable OCSiAl’s SWNTs to be used as a universal additive, simultaneously enhancing the strength and electric and thermal conductivity of polymer composites, rubbers, metals, and other materials upon the addition of as little as 0.001 to 0.1 percent by weight of TUBALL™. OCSiAl technology can serve multiple products and applications.

“Since OCSiAl’s synthesis process completely encapsulates the impurities of catalyst particles in its SWNTs, it addresses a common problem in production, namely the presence of catalyst particles that are considered impurities,” noted Valenti. “Furthermore, OCSiAl scientists plan to limit the content of the free metal particles in TUBALL™ SWNTs to 1 percent. This is significant because making SWNTs with greater purity is a major goal of nanotechnology developers.”

The potential of OCSiAl’s innovation has also helped the company grow rapidly. Recently the company has launched its online store for nanotubes to make access to small quantities of nanotubes for R&D and trial usage as easy as never before. For large quantities of nanotubes OCSiAl has launched a partnership program to create a network of OCSiAl dealers worldwide. This program will also stimulate the production of TUBALL™-enhanced versions of current products as well as the production of TUBALL™-based industrial modifiers for various materials.  It is no wonder that the company has received the 2014 Technology Innovation Award in the carbon nanotubes market.

Each year, Frost & Sullivan presents this award to the company that has demonstrated uniqueness in developing and leveraging new technologies, which significantly impacts both the functionality and the customer value of the new products and applications. The award lauds the high R&D spend toward innovation, its relevance to the industry and the positive impact on brand perception.

Frost & Sullivan’s Best Practices Awards recognize companies in a variety of regional and global markets for outstanding achievement in areas such as leadership, technological innovation, customer service, and product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research.

About OCSiAl
OCSiAl is an international technology company with operations worldwide. Named after the four major elements Oxygen (O), Carbon (C), Silicon, (Si), and Aluminum (Al), the OCSiAl offices are located in the US, Europe (UK, Luxembourg, Germany, Russia), and Asia (South Korea). OCSiAl’s team consists of 160 people, including 22 scientists and 17 managers. In 2014 OCSiAl developed a breakthrough technology for the industrial production of single-walled carbon nanotubes (SWCNT) and entered the nanomaterials market with universal additive TUBALL™.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants.

Our “Growth Partnership” supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us: Start the discussion
Join Us: Join our community
Subscribe: Newsletter on “the next big thing”
Register: Gain access to visionary innovation

Contact:

Mireya Espinoza
P: +1 210.247.3870
F: +1 210.348.1003
E: mireya.espinoza@frost.com

Photo – http://photos.prnasia.com/prnh/20141128/8521407157

ECP Health Care HOU

Philips Introduces MRI Solution to Enhance Patient Comfort and Manage Throughput

admin

— Designed for ‘first time right’ imaging to enhance patient comfort and improve workflow

ANDOVER, Mass., Dec. 2, 2014 /PRNewswire/ — Royal Philips (NYSE: PHG, AEX: PHIA) today announced the launch of Ingenia 1.5T S, a new MR system designed for “First Time Right” imaging and for faster workflow, while enhancing the patient’s experience during magnetic resonance imaging (MRI) examinations. The system joins Philips’ global portfolio of diagnostic imaging solutions designed to enhance imaging quality and help providers manage workflow efficiency.

Inconclusive image quality due to patient motion is a constant issue, making it difficult for clinicians to get accurate results in the first attempt. One repeat exam can throw off an entire day’s schedule by two to three hours, affecting throughput and patient satisfaction. Ingenia 1.5T S is designed for “First Time Right” imaging, addressing the issue in a holistic way.

“MRI scans can be very uncomfortable for patients, and we’re designing solutions that can tackle the issue in two ways: reducing the patient’s anxiety, and generating higher quality results the first time around,” said Gene Saragnese, executive vice president and CEO of Philips Imaging Systems. “Our goal is to enhance the patient experience, while equipping clinicians with the best technology to improve diagnosis.”

Ingenia 1.5T S combines superb fat-free and motion-free imaging techniques, patient-centric workflow and a unique patient experience during the exam. The system is complemented with the patient in-bore solution, which offers a comforting, engaging visual distraction. It provides patients with the option to personalize their experience by selecting a visual theme to fill the room with colorful video images, which they can view during the examination. This is combined with soothing audio to create an immersive experience, allowing the patient to relax through the exam.

The system also includes AutoVoice, to provide clear instructions and coach the patients, while scanner noise is reduced through ComforTone scan techniques. Its Premium IQ imaging, powered by dStream, allows for faster and more robust imaging, while the automated and intelligent iPatient platform provides quick patient setup, allowing clinicians to focus time on ensuring patient comfort.

“The MRI exam’s success is dependent on the patient experience: a relaxed and cooperative patient will move less, which benefits the diagnostic quality of the exam,” said Anna-Märta Strömberg, radiographer at Karolinska Children’s Hospital. “Our goal is to coach and try to soothe and relax the patient with a multi-sensory in-bore experience, so that we can complete a scan faster and more accurately.”

Ingenia 1.5T S is the newest addition to the Ingenia product line. Ingenia with dStream has been successfully installed at 1,000 hospitals across the world, along with 100 SmartPath to dStream installations. The Ingenia line of products has also received customer appreciation, winning the Best in KLAS awards in 2013 and 2014.

Philips will be showcasing its Ingenia 1.5T S solution at booth #6742 at the upcoming Radiological Society of North America (RSNA) Annual Meeting, November 30th through December 5th in Chicago, where visitors will be able to experience this new solution for themselves. For more information on Philips’ presence at #RSNA14, visit www.philips.com/rsna and follow @PhilipsHealth.

For more information on Philips innovative imaging systems that focus on the health continuum from prevention, screening and diagnosis, to treatment, recovery and wellness, visit www.philips.com/healthcare.

For further information, please contact:
Kathy O’Reilly
Philips
Tel: +1-978-659-2638
Mobile: +1-978-221-8919
Email: kathy.oreilly@philips.com
Twitter: @kathyoreilly

About Royal Philips:
Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2013 sales of EUR 23.3 billion and employs approximately 115,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter.

Photo – http://photos.prnewswire.com/prnh/20141130/161427
Photo – http://photos.prnewswire.com/prnh/20141130/161428
Photo – http://photos.prnewswire.com/prnh/20141130/161429
Logo – http://photos.prnewswire.com/prnh/20140122/NE50581LOGO

ECP Health Care

Philips Launches Integrated Patient Management Solution for Lung Cancer Screening at RSNA 2014

admin

— Facilitates implementation of lung screening programs designed to improve early-stage detection and reduce lung cancer mortality

ANDOVER, Mass., Dec. 1, 2014 /PRNewswire/ — Royal Philips (NYSE: PHG, AEX: PHIA) today introduced a new lung screening solution designed to offer health care providers a faster and more definitive pathway to lung cancer detection and treatment. Making its debut at the 2014 Radiological Society of North America (RSNA) Annual Meeting in Chicago this week, this total solution is comprised of products and services that enable health care providers to implement and manage a comprehensive computed tomography (CT) lung screening program which tracks and guides patients across the health continuum.

“Philips has long been at the forefront of offering sophisticated solutions for early detection of a wide range of conditions, but today’s clinicians need to integrate all relevant information quickly to reach a definitive diagnosis,” said Gene Saragnese, executive vice president and CEO of Imaging Systems, Philips. “Philips is in a unique position to be able to offer not only the advanced imaging technology to make early lung cancer detection possible, but the data insights, collaboration and education tools that are needed to deliver the quality and consistency required for health systems to succeed in new, evidence-based models of patient care.”

Like all cancers, the key to lung cancer survival is early detection. In 2011, the National Lung Screening Trial (NLST) showed that screening with low-dose computed tomography (CT) reduced lung cancer deaths among a population of heavy smokers by 20 percent, when compared to using chest X-rays as the diagnostic tool. At the same time, this patient population is particularly challenging to track and manage due to the high volume of measurements, data and changes in tumor and patient status over time. Philips’ innovative solution can be used with most low-dose CT scanners and consists of an integrated portfolio of products and services that together offers health care providers a complete program for early lung cancer detection and ability to easily assess individual patient status as well as overall program key performance indicators.

“Lung cancer has a significant mortality rate in the U.S., and given the large number of heavy smokers in the aging baby boomer population, we can expect to see that number rise in the coming years,” said Dr. Andrea McKee, MD, chair of the Radiation Oncology Department at Lahey Hospital and Medical Center in Burlington, MA. “Philips’ innovation in lung screening aligns with the industry’s focus on preventative screening and taking a more holistic approach to patient care.”

The Philips solution consists of several elements that, in combination, will allow health care providers to improve lung cancer screening and management with the ultimate goal of decreasing the overall mortality rate from the disease:

  • Services Marketing – Consultative services and marketing support enables health systems to reach high-risk patients and their primary care physicians (PCPs), provide connections to patient advocacy and support organizations, information sources, and access to materials for marketing their lung cancer screening services.
  • Patient Management – “Control center” software tools allow providers to follow a set of customized clinical protocols and establish interfaces with other hospital systems (HIS, RIS, EMR and PACS), providing clinical teams with a 360-degree view of patients. Customizable workflow tools also send timely and accurate notifications, and track participant history and touch points.
  • Radiology Workflow – CT lung image review and reporting offers specialized radiology software tools which facilitate review and reporting of serial CT lung exams to identify and easily follow areas of concern.
  • Physician Education Resources – Comprehensive online education portal to measure and report radiologist performance against a wide range of clinical cases, as well as structured education courses and other reference materials.

The Philips lung screening and management system will be available in North America in the first half of 2015.

Philips will showcase the lung screening and management solution in booth #6742 at the Radiological Society of North America Annual Meeting (RSNA), November 30th through December 5th in Chicago, Ill. Visit www.philips.com/rsna and follow @PhilipsHealth for more information on Philips’ presence at #RSNA14.

For more information on Philips innovative imaging systems that focus on the health continuum from prevention, screening and diagnosis, to treatment, recovery and home care, visit www.philips.com/healthcare.

For further information, please contact:
Kathy O’Reilly
Philips
Tel: +1 978-659-2638
Mobile: +1 978-221-8919
Email: kathy.oreilly@philips.com
Twitter: @kathyoreilly

About Royal Philips:

Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2013 sales of EUR 23.3 billion and employs approximately 115,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter.

Photo – http://photos.prnewswire.com/prnh/20141126/161148
Photo – http://photos.prnewswire.com/prnh/20141126/161149
Photo – http://photos.prnewswire.com/prnh/20141126/161150
Logo – http://photos.prnewswire.com/prnh/20140122/NE50581LOGO

ECP Health Care

Frost & Sullivan Recognizes ZONARE’s Pioneering Ultrasound Technology as an Enabler of Superior, Patient-Specific Imaging

admin

— ZONARE’s platform ushers in a paradigm shift in the dependence on custom-built hardware for better image quality and clinical benefits

MOUNTAIN VIEW, Calif., Dec. 1, 2014 /PRNewswire/ — Based on its recent analysis of the ultrasound imaging market, Frost & Sullivan recognizes ZONARE Medical Systems (ZONARE) with the 2014 North American Award for Enabling Technology Leadership. The company’s products tower over other commercially available products for ultrasound imaging due to the pioneering ZONE Sonography ™ Technology (ZST) platform.

Frost & Sullivan Recognizes ZONARE's Pioneering Ultrasound Technology as an Enabler of Superior, Patient-Specific Imaging

Frost & Sullivan Recognizes ZONARE’s Pioneering Ultrasound Technology as an Enabler of Superior, Patient-Specific Imaging

“ZONARE’s ZST is an innovative new technology platform that enables better image quality, marking a departure from the industry’s standard image acquisition techniques,” said Frost & Sullivan Research Analyst Bhargav Rajan. “ZST provides superior, highly focused and patient-specific images by personalizing the imaging process in patients.”

While conventional ultrasound instruments employ a line-by-line approach to image capture, the ZST takes a “zone” approach by reducing the number of data sets and transmit-receive cycles. Consequently, ZONARE systems offer multiple benefits. First, ZST’s data acquisition is nearly 10 times faster, improving temporal accuracy during real-time imaging. Second, ZST facilitates greater focus and retrospective image analysis of larger sample areas. Finally, because of the speed of data capture, the variations in sound propagation through the patient’s body are rendered minimal and cease to impact image quality.

“In developing ZST, ZONARE has ushered in a paradigm shift in the dependence on custom-built hardware for better image quality and clinical benefits,” noted Rajan. “ZST is effectively integrated into the data acquisition and image processing ends of the imaging process. A key indicator of ZST’s positive impact on the ultrasound imaging industry is the variety of applications that it has successfully enabled.”

Extensively used in radiology, vascular imaging, cardiac imaging, emergency medicine, surgery, pediatrics, and pre- and neonatal care, ZONARE has designed systems to meet the unique demands of each area in terms of transducer design requirements and patient profiles. All the systems maintain a small system footprint to enable point-of-care imaging, and have an intuitive and easy-to-use interface to minimize operator errors.

Further, ZONARE offers higher price performance value through its Living Technology™ program. This novel business initiative offers customers upgrades and service support for five years to keep their product state of the art. Further, ZONARE’s family of ultrasound devices has secured the Food and Drug Administration’s 510(K) clearance for clinical use within the United States. The products have the CE mark necessary for use in European countries and various other regional regulatory certificates. ZONARE has successfully installed more than 10,000 ultrasound systems in over 70 countries.

Its innovative technology platform, unique product positioning, and long-term customer engagement will ensure ZONARE’s continued leadership in the industry. The company has over 70 worldwide patents, which offer it much-needed protection while expanding into newer application areas and regional markets. In July 2013, ZONARE was acquired by Mindray Medical (Shenzhen, China) and set up as an independently run subsidiary. The acquisition is a testimony to ZONARE’s powerful market position and has given the company access to markets in China, Europe and Asia Pacific.

With its strong overall performance, ZONARE is the worthy recipient of the 2014 North American Frost & Sullivan Enabling Technology Leadership Award in ultrasound imaging. Each year, Frost & Sullivan presents this award to a company that has developed a pioneering technology that not only enhances current products, but also enables the development of newer products and applications. The award recognizes the high market acceptance potential of the recipient’s technology.

Frost & Sullivan’s Best Practices Awards recognize companies in a variety of regional and global markets for outstanding achievement in areas such as leadership, technological innovation, customer service, and product development. Industry analysts compare market participants and measure performance through in-depth interviews, analysis, and extensive secondary research.

About ZONARE

ZONARE is solely dedicated to ultrasound excellence through its innovative, award-winning next generation technology which provides the platform for the company’s Living Technology designed to meet its customers evolving imaging needs. The patented design and Zone Sonography ™ Technology (ZST) architecture of the z.one ultra, Z.One PRO and ZS3 platforms deliver high-end image quality and clinical versatility. The company recently was given the 2014 North American Ultrasound Enabling Technology Leadership Award by Frost & Sullivan, the third time in ZONARE’s history. ZONARE is an independently run, wholly owned subsidiary of Mindray Medical International.  For more information, visit www.zonare.com.

About Frost & Sullivan

Frost & Sullivan, the Growth Partnership Company, works in collaboration with clients to leverage visionary innovation that addresses the global challenges and related growth opportunities that will make or break today’s market participants.

Our “Growth Partnership” supports clients by addressing these opportunities and incorporating two key elements driving visionary innovation: The Integrated Value Proposition and The Partnership Infrastructure.

  • The Integrated Value Proposition provides support to our clients throughout all phases of their journey to visionary innovation including: research, analysis, strategy, vision, innovation and implementation.
  • The Partnership Infrastructure is entirely unique as it constructs the foundation upon which visionary innovation becomes possible. This includes our 360 degree research, comprehensive industry coverage, career best practices as well as our global footprint of more than 40 offices.

For more than 50 years, we have been developing growth strategies for the global 1000, emerging businesses, the public sector and the investment community. Is your organization prepared for the next profound wave of industry convergence, disruptive technologies, increasing competitive intensity, Mega Trends, breakthrough best practices, changing customer dynamics and emerging economies?

Contact Us:     Start the discussion 

Join Us:           Join our community 

Subscribe:       Newsletter on “the next big thing” 

Register:        Gain access to visionary innovation

Contact:

Mireya Espinoza 
P: +1 210.247.3870
F: +1 210.348.1003
E: mireya.espinoza@frost.com 

Laurie Hallwyler
P: +1 650.248.9081
E: lhallwyler@zonare.com

Photo – http://photos.prnasia.com/prnh/20141128/8521407118

ECP Health Care HOU

Philips launches DoseWise Portal at RSNA 2014, industry’s first integrated radiation dose management solution for patients and clinicians

admin

— Only solution to track, analyze and mitigate radiation risk for both clinicians and patients; facilitates compliance with increased dose monitoring standards

ANDOVER, Mass. and CHICAGO, Dec. 1, 2014 /PRNewswire/ — Royal Philips (NYSE: PHG, AEX: PHIA) today introduced the DoseWise Portal, a comprehensive radiation dose management software solution aimed at managing radiation exposure risk to patients and their caregivers. Announced at the 100th annual meeting of the Radiological Society of North America (RSNA), the Philips DoseWise Portal enables health care providers to proactively record, analyze and monitor imaging radiation dose for patients and clinicians across multiple diagnostic settings.

Photo – http://photos.prnewswire.com/prnh/20141130/161421-INFO
Photo – http://photos.prnewswire.com/prnh/20141130/161420
Photo – http://photos.prnewswire.com/prnh/20141130/161422
Logo – http://photos.prnewswire.com/prnh/20140122/NE50581LOGO

While the risk of radiation exposure through imaging scans is thought to be low, and the diagnostic rewards generally outweigh those risks, the industry has committed to reducing radiation exposure through improvements in technology and user training. Computer tomography (CT) scans are of most concern, with a higher average diagnostic radiation dose per scan and nearly 68 million performed annually in the U.S.

“Dose management is a critical issue, and the reality is that sometimes the higher radiation dose of a CT is necessary for a particular patient to in order reach a definitive diagnosis, in the shortest time, and at the lowest cost,” said Gene Saragnese, executive vice president and CEO of Philips Imaging Systems. “Philips DoseWise Solutions return a measure of control to patient care, arming clinicians and informing patients with the tools, training and insights they need in order to ask the right questions regarding radiation dose.”

Over the past several years, industry standards like MITA XR-29 have provided health care providers with more standardized tools for patient radiation dose management. At the same time, hospitals and health systems looking to better protect patients and clinicians have been forced to tackle the problem independently, using multiple vendors to bring dose management into focus. Philips DoseWise Solutions include a comprehensive portfolio of products and services including ClarityIQ, IMR and DoseAware, that empower health care providers with both the data and support they need to implement a broad and comprehensive dose management strategy.

“Understanding and delivering the right dose for each person each time, and tracking and analyzing exposure over time, requires more than just technology, but also involves a new way managing radiation safety,” said Christoph Wald, MD PhD and Executive Vice Chair, Department of Radiology at Lahey Hospital and Medical Center in Burlington, MA. “Philips DoseWise is the first integrated, holistic solution that integrates staff and patient dose protecting both patients and clinicians and helping us to comply with critical new dose management standards and regulations.”

Philips is showcasing DoseWise in booth #6742 at the Radiological Society of North America Annual Meeting (RSNA), November 30th through December 5th in Chicago, Ill. Visit www.philips.com/rsna and follow @PhilipsHealth for more information on Philips’ presence at #RSNA14.

For more information on Philips innovative imaging systems that focus on the health continuum from prevention, screening and diagnosis, to treatment, recovery and home care, visit www.philips.com/healthcare.

For further information, please contact:
Kathy O’Reilly
Philips
Tel: +1-978-659-2638
Mobile: +1-978-221-8919
Email: kathy.oreilly@philips.com
Twitter: @kathyoreilly

About Royal Philips:

Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2013 sales of EUR 23.3 billion and employs approximately 115,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter.

ECP Health Care

Philips expands global reach of diagnostic X-Ray solutions

admin

–Complete portfolio now offers tailor-made diagnostic X-ray solutions for any customer worldwide

ANDOVER, Massachusetts, Nov. 26, 2014 /PRNewswire/ — Royal Philips (NYSE: PHG AEX: PHIA) today announced expanded availability of its portfolio of diagnostic X-ray solutions, including DuraDiagnost, DigitalDiagnost, MobileDiagnost wDR, MobileDiagnost Opta[i] , ProGrade and PrimaryDiagnost[ii]. With new releases of several of these solutions now available in the U.S., and availability of all these solutions in new global markets, the portfolio offers Philips’ customers innovative solutions designed to meet the needs and overcome the challenges of diagnostic X-ray environments across the world.

Logo – http://photos.prnewswire.com/prnh/20140122/NE50581LOGO
Photo – http://photos.prnewswire.com/prnh/20141125/160969
Photo – http://photos.prnewswire.com/prnh/20141125/160967

“Philips understands that a one-size-fits-all approach in health care just doesn’t work. We serve a wide range of customers around the world, and their needs vary depending on a number of factors, including the economic pressures, patient populations and regulatory landscape in their local markets,” said Bert van Meurs, General Manager, Integrated Clinical Solutions, Philips Healthcare. “Our diagnostic X-ray portfolio provides meaningful solutions for health care providers looking to take advantage of digital radiography, in any region of the world.”

Central to the solutions in the Philips DR portfolio is the new SkyPlate portable detector, which offers cassette-sized wireless sharing across Philips’ compatible digital radiography systems. In addition, Philips’ SkyFlow technology, available on DigitalDiagnost and MobileDiagnost wDR, keeps providers at the forefront of clinical performance by allowing clinicians to combine the ease of the grid-less acquisition workflow for bedside chest radiography with detail contrast offering grid-like images. The Eleva user interface, designed for fast, consistent workflow results, also offers pre-settings, customizable user profiles and rapid image availability. All systems also share Philips’ Unified Image Quality Enhancement (UNIQUE) software that allows for consistent imaging across all anatomical areas, which aims to limit the number of follow-up exams and additional X-ray dose.

From the DuraDiagnost enabling fast exam set up and workflow efficiency, to the DigitalDiagnost designed to address the advanced demands of busy medical facilities, to MobileDiagnost wDR and MobileDiagnost Opta providing bedside, on-the-spot imaging capabilities, the Philips DR suite provides a solution for virtually any clinical environment. The portfolio rounds out with ProGrade, upgrading providers to a fully integrated, digital imaging experience using BuckyDiagnost, and PrimaryDiagnost, which achieved its first installation in July 2014.

“With Philips, we’ve moved from ordering a piece of equipment to an established long-term partnership. That partnership allows us to take a long view of how we will improve care,” said Dr. James V. Rawson, Chief of Radiology, Georgia Regents Medical Center. “When we replaced the digital portable X-ray units in the ICU, we completely changed the workflow. After an X-ray was taken in the ICU, the image was immediately available at that bedside for the physician to be able to see. That allowed real-time decisions and corrections or repositioning of lines and repeating at the X-ray, and cut our cycle-time down substantially.”

Philips will be showcasing its diagnostic X-ray solutions at booth #6742 of the upcoming Radiological Society of North America Annual Meeting, November 30th through December 5th in Chicago, Ill. Follow @PhilipsHealth for more information on Philips’ presence at #RSNA14.

For more information on Philips’ integrated portfolio of radiography solutions, visit: www.philips.com/digital_radiography.

About Royal Philips:

Royal Philips (NYSE: PHG, AEX: PHIA) is a diversified health and well-being company, focused on improving people’s lives through meaningful innovation in the areas of Healthcare, Consumer Lifestyle and Lighting. Headquartered in the Netherlands, Philips posted 2013 sales of EUR 23.3 billion and employs approximately 115,000 employees with sales and services in more than 100 countries. The company is a leader in cardiac care, acute care and home healthcare, energy efficient lighting solutions and new lighting applications, as well as male shaving and grooming and oral healthcare. News from Philips is located at www.philips.com/newscenter.

[i] Not available in the U.S.A.
[ii] Not available in the U.S.A.